↓ Skip to main content

The benefits of GLP1 receptors in cardiovascular diseases

Overview of attention for article published in Frontiers in Clinical Diabetes and Healthcare, December 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 191)
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
3 news outlets
twitter
4 X users

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The benefits of GLP1 receptors in cardiovascular diseases
Published in
Frontiers in Clinical Diabetes and Healthcare, December 2023
DOI 10.3389/fcdhc.2023.1293926
Pubmed ID
Authors

Lamija Ferhatbegović, Denis Mršić, Amra Macić-Džanković

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 8%
Other 2 5%
Unspecified 2 5%
Student > Bachelor 2 5%
Student > Ph. D. Student 2 5%
Other 3 8%
Unknown 23 62%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 16%
Biochemistry, Genetics and Molecular Biology 3 8%
Unspecified 2 5%
Medicine and Dentistry 2 5%
Nursing and Health Professions 1 3%
Other 0 0%
Unknown 23 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2024.
All research outputs
#1,722,227
of 26,287,478 outputs
Outputs from Frontiers in Clinical Diabetes and Healthcare
#7
of 191 outputs
Outputs of similar age
#28,065
of 383,818 outputs
Outputs of similar age from Frontiers in Clinical Diabetes and Healthcare
#2
of 23 outputs
Altmetric has tracked 26,287,478 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 191 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 383,818 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.